Literature DB >> 14629470

LMAN1 is a molecular chaperone for the secretion of coagulation factor VIII.

M A Cunningham1, S W Pipe, B Zhang, H-P Hauri, D Ginsburg, R J Kaufman.   

Abstract

Combined deficiency of both coagulation factors (F)V and VIII is a rare autosomal recessive bleeding disorder caused by null expression of LMAN1 (previously termed ERGIC-53) in a majority of affected individuals. Previously, a requirement for a functional LMAN1 cycling pathway between the ER and Golgi was demonstrated for efficient secretion of FV and FVIII (Moussalli et al. J Biol Chem 1999; 274: 32569), however, the molecular nature of the interaction between LMAN1 and its cargo was not characterized. Using coimmunoprecipitation of LMAN1 and FVIII from transfected HeLa and COS-1 cells, we demonstrate an interaction between LMAN1 and FVIII in vivo. The interaction was mediated via high mannose-containing asparagine-linked oligosaccharides that are densely situated within the B domain of FVIII, as well as protein-protein interactions. These results are interpreted based on the recent determination of the crystal structure of the carbohydrate recognition domain of LMAN1.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14629470     DOI: 10.1046/j.1538-7836.2003.00415.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  10 in total

1.  Carbohydrate- and conformation-dependent cargo capture for ER-exit.

Authors:  Christian Appenzeller-Herzog; Beat Nyfeler; Peter Burkhard; Inigo Santamaria; Carlos Lopez-Otin; Hans-Peter Hauri
Journal:  Mol Biol Cell       Date:  2005-01-05       Impact factor: 4.138

2.  Combined deficiency of factor V and factor VIII is due to mutations in either LMAN1 or MCFD2.

Authors:  Bin Zhang; Beth McGee; Jennifer S Yamaoka; Hugo Guglielmone; Katharine A Downes; Salvador Minoldo; Gustavo Jarchum; Flora Peyvandi; Norma B de Bosch; Arlette Ruiz-Saez; Bernard Chatelain; Marian Olpinski; Paula Bockenstedt; Wolfgang Sperl; Randal J Kaufman; William C Nichols; Edward G D Tuddenham; David Ginsburg
Journal:  Blood       Date:  2005-11-22       Impact factor: 22.113

3.  Advancements in gene transfer-based therapy for hemophilia A.

Authors:  Christopher B Doering; H Trent Spencer
Journal:  Expert Rev Hematol       Date:  2009-12       Impact factor: 2.929

Review 4.  Recent developments in the understanding of the combined deficiency of FV and FVIII.

Authors:  Bin Zhang
Journal:  Br J Haematol       Date:  2009-01-16       Impact factor: 6.998

5.  Structural characterization of carbohydrate binding by LMAN1 protein provides new insight into the endoplasmic reticulum export of factors V (FV) and VIII (FVIII).

Authors:  Chunlei Zheng; Richard C Page; Vaijayanti Das; Jay C Nix; Edvard Wigren; Saurav Misra; Bin Zhang
Journal:  J Biol Chem       Date:  2013-05-24       Impact factor: 5.157

6.  The enhancing effects of the light chain on heavy chain secretion in split delivery of factor VIII gene.

Authors:  Lingxia Chen; Fuxiang Zhu; Juan Li; Hui Lu; Haiyan Jiang; Rita Sarkar; Valder R Arruda; Jinhui Wang; Jennifer Zhao; Glenn F Pierce; Qiulan Ding; Xuefeng Wang; Hongli Wang; Steven W Pipe; Xiang-Qin Liu; Xiao Xiao; Rodney M Camire; Weidong Xiao
Journal:  Mol Ther       Date:  2007-07-24       Impact factor: 11.454

7.  Enhanced factor VIII heavy chain for gene therapy of hemophilia A.

Authors:  Lingxia Chen; Hui Lu; Jinhui Wang; Rita Sarkar; Xiao Yang; Hongli Wang; Katherine A High; Weidong Xiao
Journal:  Mol Ther       Date:  2009-01-06       Impact factor: 11.454

8.  Engineering Factor Viii for Hemophilia Gene Therapy.

Authors:  Sean A Roberts; Biao Dong; Jenni A Firrman; Andrea R Moore; Nianli Sang; Weidong Xiao
Journal:  J Genet Syndr Gene Ther       Date:  2011-12-21

9.  Removal of Mannose-Ending Glycan at Asn2118 Abrogates FVIII Presentation by Human Monocyte-Derived Dendritic Cells.

Authors:  Sandrine Delignat; Julie Rayes; Suryasarathi Dasgupta; Bagirath Gangadharan; Cécile V Denis; Olivier D Christophe; Jagadeesh Bayry; Srinivas V Kaveri; Sébastien Lacroix-Desmazes
Journal:  Front Immunol       Date:  2020-03-26       Impact factor: 7.561

Review 10.  To clear or to fear: An innate perspective on factor VIII immunity.

Authors:  Jesse Derek Lai; Maria Teofana Georgescu; Christine Hough; David Lillicrap
Journal:  Cell Immunol       Date:  2015-10-28       Impact factor: 4.868

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.